An underestimated cause of chronic cough: The Protracted Bacterial Bronchitis.

Authors:
Alessandra Scaparrotta
Alessandra Scaparrotta
University of Chieti
Italy
Marianna Immacolata Petrosino
Marianna Immacolata Petrosino
University of Chieti
Marina Attanasi
Marina Attanasi
University of Chieti
Chieti | Italy
Sabrina Di Pillo
Sabrina Di Pillo
University of Chieti
Italy
Francesco Chiarelli
Francesco Chiarelli
University of Chieti
Italy
Angelika Mohn
Angelika Mohn
University of Chieti
Italy

Ann Thorac Med 2018 Jan-Mar;13(1):7-13

Department of Pediatrics, University of Chieti, 66100 Chieti, Italy.

Chronic cough in childhood is associated with a high morbidity and decreased quality of life. Protracted bacterial bronchitis (PBB) seems to be the second most common cause of chronic cough in children under 6 years of age. Its main clinical feature is represented by wet cough that worsens when changing posture and improves after the introduction of antibiotics. Currently, the mainstay of PBB treatment is a 2-week therapy with a high dose of antibiotics, such as co-amoxiclav, to eradicate the infection and restore epithelial integrity. It is very important to contemplate this disease in a child with chronic cough since the misdiagnosis of PBB could lead to complications such as bronchiectasis. Clinicians, however, often do not consider this disease in the differential diagnosis and, consequently, they are inclined to change the antibiotic therapy rather than to extend it or to add steroids. Data sources of this review include PubMed up to December 2016, using the search terms "child," "chronic cough," and "protracted bacterial bronchitis."

Download full-text PDF

Source
http://dx.doi.org/10.4103/atm.ATM_12_17DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772114PMC
February 2018
12 Reads

Publication Analysis

Top Keywords

chronic cough
16
protracted bacterial
8
bacterial bronchitis
8
cough
5
contemplate disease
4
disease child
4
epithelial integrity
4
restore epithelial
4
child chronic
4
integrity contemplate
4
misdiagnosis pbb
4
complications bronchiectasis
4
bronchiectasis clinicians
4
lead complications
4
pbb lead
4
infection restore
4
cough misdiagnosis
4
dose antibiotics
4
currently mainstay
4
mainstay pbb
4

Similar Publications

Protracted bacterial bronchitis: The last decade and the road ahead.

Pediatr Pulmonol 2016 Mar 4;51(3):225-42. Epub 2015 Dec 4.

Queensland Children's Medical Research Institute, Children's Health Queensland, Brisbane, Queensland, Australia.

Cough is the single most common reason for primary care physician visits and, when chronic, a frequent indication for specialist referrals. In children, a chronic cough (>4 weeks) is associated with increased morbidity and reduced quality of life. One common cause of childhood chronic cough is protracted bacterial bronchitis (PBB), especially in children aged <6 years. Read More

View Article
March 2016

Pro-Con Debate: Protracted Bacterial Bronchitis as a Cause of Chronic Cough in Children.

Pediatr Ann 2015 Aug;44(8):329-36

Pro: Children with chronic cough present a diagnostic challenge. Protracted bacterial bronchitis (PBB) is a chronic, persistent bacterial infection of conducting airways defined by the presence of cough for longer than 4 weeks that resolves with antimicrobial therapy and without an alternative diagnosis. The diagnosis is made by the findings of increased bronchial secretions and edema of the lower airways on flexible bronchoscopy and positive cultures on bronchoalveolar lavage. Read More

View Article
August 2015

Chronic wet cough: Protracted bronchitis, chronic suppurative lung disease and bronchiectasis.

Pediatr Pulmonol 2008 Jun;43(6):519-31

Child Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Australia.

The role of persistent and recurrent bacterial infection of the conducting airways (endobronchial infection) in the causation of chronic respiratory symptoms, particularly chronic wet cough, has received very little attention over recent decades other than in the context of cystic fibrosis (CF). This is probably related (at least in part) to the (a) reduction in non-CF bronchiectasis in affluent countries and, (b) intense focus on asthma. In addition failure to characterize endobronchial infections has led to under-recognition and lack of research. Read More

View Article
June 2008

Does a 10-valent pneumococcal-Haemophilus influenzae protein D conjugate vaccine prevent respiratory exacerbations in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: protocol for a randomised controlled trial.

Trials 2013 Sep 5;14:282. Epub 2013 Sep 5.

Queensland Children's Medical Research Institute, Royal Children's Hospital, The University of Queensland, Brisbane, QLD, Australia.

Background: Recurrent protracted bacterial bronchitis (PBB), chronic suppurative lung disease (CSLD) and bronchiectasis are characterised by a chronic wet cough and are important causes of childhood respiratory morbidity globally. Haemophilus influenzae and Streptococcus pneumoniae are the most commonly associated pathogens. As respiratory exacerbations impair quality of life and may be associated with disease progression, we will determine if the novel 10-valent pneumococcal-Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) reduces exacerbations in these children. Read More

View Article
September 2013